JP2004523553A5 - - Google Patents

Download PDF

Info

Publication number
JP2004523553A5
JP2004523553A5 JP2002567289A JP2002567289A JP2004523553A5 JP 2004523553 A5 JP2004523553 A5 JP 2004523553A5 JP 2002567289 A JP2002567289 A JP 2002567289A JP 2002567289 A JP2002567289 A JP 2002567289A JP 2004523553 A5 JP2004523553 A5 JP 2004523553A5
Authority
JP
Japan
Prior art keywords
pain
formula
composition
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002567289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004523553A (ja
JP4276838B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/005421 external-priority patent/WO2002067922A1/en
Publication of JP2004523553A publication Critical patent/JP2004523553A/ja
Publication of JP2004523553A5 publication Critical patent/JP2004523553A5/ja
Application granted granted Critical
Publication of JP4276838B2 publication Critical patent/JP4276838B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002567289A 2001-02-27 2002-02-21 疼痛(pain)の治療における使用のためのカルバメート化合物 Expired - Fee Related JP4276838B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
PCT/US2002/005421 WO2002067922A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Publications (3)

Publication Number Publication Date
JP2004523553A JP2004523553A (ja) 2004-08-05
JP2004523553A5 true JP2004523553A5 (cg-RX-API-DMAC10.html) 2005-12-22
JP4276838B2 JP4276838B2 (ja) 2009-06-10

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567289A Expired - Fee Related JP4276838B2 (ja) 2001-02-27 2002-02-21 疼痛(pain)の治療における使用のためのカルバメート化合物

Country Status (28)

Country Link
US (1) US6815464B2 (cg-RX-API-DMAC10.html)
EP (1) EP1404312B1 (cg-RX-API-DMAC10.html)
JP (1) JP4276838B2 (cg-RX-API-DMAC10.html)
KR (1) KR100906315B1 (cg-RX-API-DMAC10.html)
CN (1) CN1849116A (cg-RX-API-DMAC10.html)
AR (1) AR033427A1 (cg-RX-API-DMAC10.html)
AT (1) ATE493125T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002254015B2 (cg-RX-API-DMAC10.html)
BR (1) BR0207673A (cg-RX-API-DMAC10.html)
CA (1) CA2439274C (cg-RX-API-DMAC10.html)
CY (1) CY1111349T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20032298A3 (cg-RX-API-DMAC10.html)
DE (1) DE60238765D1 (cg-RX-API-DMAC10.html)
DK (1) DK1404312T3 (cg-RX-API-DMAC10.html)
ES (1) ES2356617T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0303236A3 (cg-RX-API-DMAC10.html)
IL (1) IL157593A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA03007721A (cg-RX-API-DMAC10.html)
MY (1) MY129312A (cg-RX-API-DMAC10.html)
NO (1) NO20033804L (cg-RX-API-DMAC10.html)
NZ (1) NZ527994A (cg-RX-API-DMAC10.html)
PL (1) PL364647A1 (cg-RX-API-DMAC10.html)
PT (1) PT1404312E (cg-RX-API-DMAC10.html)
RS (1) RS67603A (cg-RX-API-DMAC10.html)
RU (1) RU2283106C2 (cg-RX-API-DMAC10.html)
TW (1) TWI304735B (cg-RX-API-DMAC10.html)
WO (1) WO2002067922A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200307475B (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007934A1 (en) * 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1998781A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Treatment of pain
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
EP2496227B1 (en) 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
ES2447295T3 (es) 2009-11-06 2014-03-11 Sk Biopharmaceuticals Co., Ltd. Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
RU2632659C2 (ru) * 2011-12-27 2017-10-09 Байо-Фарм Солюшнс Ко., Лтд. Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
ATE226071T1 (de) * 1996-10-08 2002-11-15 Ortho Mcneil Pharm Inc Antikonvulsive derivate zur behandlung von neuropathischem schmerz
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
PL365701A1 (en) 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Similar Documents

Publication Publication Date Title
CA2439274A1 (en) Carbamate compounds for use in the treatment of pain
ES2738826T3 (es) Compuestos de piridilo sustituidos con alquilamida útiles como moduladores de respuestas de IL-12, IL-23 y/o IFNalfa
ES2335498T3 (es) Nuevo proceso para la preparacion de reflumilast.
HRP20230377T1 (hr) Inhibitori mutacije kras g12c
ES2228127T3 (es) Derivados de pirazolopiridina como inhibidores selectivos de cox-2.
CN1140267C (zh) 治疗环加氧酶-2介导的疾病的每天一次的组合物
ES2216631T3 (es) Pirazolpiridinas.
JP2014139226A5 (cg-RX-API-DMAC10.html)
TW200808314A (en) Treatment of chemokine mediated diseases
ES2961499T3 (es) Inhibidores de LSD1 y usos médicos de los mismos
JP2010150273A5 (cg-RX-API-DMAC10.html)
EP1979349A2 (en) Anti-viral compounds
KR20160034316A (ko) 글리옥사미드 치환된 피롤아미드 유도체 및 b형 간염 치료용 의약으로서의 이의 용도
CN111406063A (zh) 作为抗癌剂的环二核苷酸
EA200400488A1 (ru) Бензамид и гетероариламид в качестве антагонистов рецептора p2x
CN1173872A (zh) 凝血酶抑制剂
JP2011527333A5 (cg-RX-API-DMAC10.html)
JP2004517813A5 (cg-RX-API-DMAC10.html)
WO2010000031A1 (en) Imidazopyrimidinones and uses thereof
RU2007133802A (ru) Кристаллические формы производной имидазола
TW202421132A (zh) 作為nlrp3發炎體之抑制劑之吲唑及吡唑并吡啶化合物
JP2014527057A (ja) プロリンリッチペプチドの構造模倣物およびその使用
CN114007652A (zh) 小分子靶向溴/乙酰蛋白及其用途
JP2017531680A (ja) 三環式アトロプ異性体の化合物
EP4469460A1 (en) N-oxide inhibitors of nlrp3 inflammasome